Introducing the TMCx09 Medical Device Cohort Companies
We are delighted to announce the 16 companies that were selected for our TMCx09 Medical Device Cohort! Our team went through 140 applications to narrow down the top 40 companies to do in-person and virtual interviews. We’re excited to include 9international companies and 7 US-based companies, 4 of which are from Houston! Our new companies below will be joining us on Monday, August 5th to kickoff their time at TMCx!
Neurescue | Copenhagen, Denmark
Neurescue has developed a computer-aided aortic occlusion catheter to help save the lives of patients in the emergency care setting.
Venari Medical is developing BioVena — a medical device that treats varicose veins and venous leg ulcers with a minimally invasive approach intended to reduce pain.
Obsidio is developing a universal gel embolic material to shrink lesions or to treat internal bleeds, aneurysms and vascular malformations.
PATH EX is developing an extracorporeal blood cleansing device designed to selectively remove pathogens, including multi-drug resistant bacteria, and endotoxins from circulating blood to diagnose and treat sepsis.
Innosphere is a medical device company developing brain stimulation solutions for treating cognitive disorders, with a focus on ADHD.
AbiliTech is restoring independence to patients with upper limb neuromuscular conditions by offering a wearable assistive device that allows the user to perform independent activities of daily living.
Komodo OpenLab has developed Tecla, an assistive device giving individuals with physical disabilities the ability to communicate, control, and connect with the world.
CorInnova has developed a soft robotic non-blood contacting biventricular cardiac assist device for the treatment of heart failure that would eliminate the many adverse events associated with current technologies.
Ictero Medical is developing a minimally invasive ablation solution to treat high-risk patients with gallstone disease and offer patients the benefits of surgery without the risk.
Artidis has developed a nanomechanical biomarker technology using precise tissue measurement in combination with data analytics to personalize cancer diagnosis.
Inveox automates the pre-analytical process in cancer diagnosis to improve patient safety and lab efficiency.
TOWARD HOME HEALTH
Kegg is on a mission to simplify every woman’s journey towards taking charge of her fertility with a user-friendly monitoring device.
TestCard is a flat pack urine test kit that functions in combination with a mobile phone application, turning a phone’s camera into a clinical grade scanner.
Patch’d uses deep learning and wearable devices to predict the onset of sepsis in the at-home patient.
Volumetric’s 3D bioprinting platform creates materials with living cells with applications in biomaterials, cancer research, and eventually human organ replacements.
Tevasol is developing organ transplant transportation solutions. Their portable warm perfusion machines will help surgeons transplant more organs today and solve organ shortage tomorrow.
We are eager to get started! If you are looking for more information or to be connected with any of these companies, please email Emily Reiser, Innovation Strategist at firstname.lastname@example.org.